PATENT CLAIM ANALYSIS

Application Number: 15886014
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "252000"]

Abstract:
The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.

Claim (Index 16):
A method of modulating a cellular process (for example cell division) by inhibiting the activity of a cyclin dependent kinase using a compound according to any one of  claims 1  to  12 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.53704
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13060154', '14158358', '12545322', '13579359', '13786955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8227950612444106
- 35 USC 102 Novelty (BERT): 0.5821160677332934
- Combined Prediction Score: 0.798727161893299
- Mean Citation Score: 489.78964
- Max Citation Score: 549.5182
- Similarity Product: 360.2728179231644

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test